Use of CNS medications and cognitive decline in the aged: A longitudinal population-based study

BMC Geriatrics

Volumn 11, Issue , 2011, Pages

  Puustinen, Juha ^a,b,c,d   Nurminen, Janne ^a,c,d,e   Löppönen, Minna ^a,c   Vahlberg, Tero ^a   Isoaho, Raimo ^a   Räihä, Ismo ^a   Kivelä, Sirkka Liisa ^a,b,d  

^a UNIVERSITY OF TURKU   (Finland)

^b SATAKUNTA CENTRAL HOSPITAL   (Finland)

^c Harkatie Health Centre   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e Turku Health Centre   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CENTRAL NERVOUS SYSTEM AGENTS; NARCOTIC ANALGESIC AGENT;

AGED; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG COMBINATION; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; LONGITUDINAL STUDY; MALE; METHODOLOGY; PSYCHOLOGICAL ASPECT;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; BENZODIAZEPINES; BRIEF PSYCHIATRIC RATING SCALE; CENTRAL NERVOUS SYSTEM AGENTS; COGNITION DISORDERS; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; POPULATION SURVEILLANCE;

EID: 80055041501     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-11-70     Document Type: Article

References (30)

1. The use of psychoactive medications and cognitive function in older adults. Berg S, Dellasega C, J Aging Health 1996 8 1 136 149 10.1177/089826439600800107 10160568 (Pubitemid 26039743)
2. Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition Study. Wright RM, Roumani YF, Boudreau R, Newman AB, Ruby CM, Studenski SA, Shorr RI, Bauer DC, Simonsick EM, Hilmer SN, Hanlon JT, J Am Geriatr Soc 2009 57 2 243 250 10.1111/j.1532-5415.2008.02127.x 19207141
3. The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent? Bierman EJ, Comijs HC, Gundy CM, Sonnenberg C, Jonker C, Beekman AT, Int J Geriatr Psychiatry 2007 22 12 1194 1200 10.1002/gps.1811 17407168 (Pubitemid 350285423)
4. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. Paterniti S, Dufouil C, Alperovitch A, J Clin Psychopharmacol 2002 22 3 285 293 10.1097/00004714-200206000-00009 12006899 (Pubitemid 34546844)
5. Benzodiazepine use and risk of dementia: a nested case-control study. Lagnaoui R, Begaud B, Moore N, Chaslerie A, Fourrier A, Letenneur L, Dartigues JF, Moride Y, J Clin Epidemiol 2002 55 3 314 318 10.1016/S0895-4356(01)00453-X 11864804 (Pubitemid 34195529)
6. Benzodiazepine use and cognitive function among community-dwelling elderly. Hanlon JT, Horner RD, Schmader KE, Fillenbaum GG, Lewis IK, Wall WE, Landerman LR, Pieper CF, Blazer DG, Cohen HJ, Clin Pharmacol Ther 1998 64 6 684 692 10.1016/S0009-9236(98)90059-5 9871433 (Pubitemid 29011388)
7. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Carriere I, Fourrier-Reglat A, Dartigues JF, Rouaud O, Pasquier F, Ritchie K, Ancelin ML, Arch Intern Med 2009 169 14 1317 1324 10.1001/archinternmed.2009.229 19636034
8. Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. Han L, Agostini JV, Allore HG, J Am Geriatr Soc 2008 56 12 2203 2210 10.1111/j.1532-5415.2008.02009.x 19093918
9. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K, Bmj 2006 332 7539 455 459 10.1136/bmj.38740.439664.DE 16452102 (Pubitemid 43342043)
10. Sedative-hypnotic use of diphenhydramine in a rural, older adult, community-based cohort: effects on cognition. Basu R, Dodge H, Stoehr GP, Ganguli M, Am J Geriatr Psychiatry 2003 11 2 205 213 12611750 (Pubitemid 36254194)
11. Long-term cognitive impact of anticholinergic medications in older adults. Bottiggi KA, Salazar JC, Yu L, Caban-Holt AM, Ryan M, Mendiondo MS, Schmitt FA, Am J Geriatr Psychiatry 2006 14 11 980 984 10.1097/01.JGP. 0000224619.87681.71 17068321 (Pubitemid 44706417)
12. Prevalence of asthma in elderly Finns. Isoaho R, Puolijoki H, Huhti E, Kivela SL, Tala E, J Clin Epidemiol 1994 47 10 1109 1118 10.1016/0895-4356(94) 90097-3 7722544 (Pubitemid 24322806)
13. Diagnosing cognitive impairment and dementia in primary health care - a more active approach is needed. Lopponen M, Raiha I, Isoaho R, Vahlberg T, Kivela SL, Age Ageing 2003 32 6 606 612 10.1093/ageing/afg097 14600001 (Pubitemid 37461568)
14. Psychotropics among the home-dwelling elderly - increasing trends. Linjakumpu T, Hartikainen S, Klaukka T, Koponen H, Kivela SL, Isoaho R, Int J Geriatr Psychiatry 2002 17 9 874 883 10.1002/gps.712 12221663
15. Use of medications and polypharmacy are increasing among the elderly. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R, Journal of clinical epidemiology 2002 55 8 809 817 10.1016/S0895-4356(02)00411-0 12384196
16. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Folstein MF, Folstein SE, McHugh PR, J Psychiatr Res 1975 12 3 189 198 10.1016/0022-3956(75)90026-6 1202204
17. National Agency of Medicines, Classification of Medicines (ATC) and Defined Daily Doses (DDD) Helsinki 1996
18. Indikatorer för utvärdering av kvaliteten i äldres läkemedelsterapi [Indicators for evaluating the quality of medication therapy in the aged]. Socialstyrelsen, Stockholm 2003 Report No.: 2003-110-20: 74
19. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH, Arch Intern Med 2003 163 22 2716 2724 10.1001/archinte.163.22.2716 14662625 (Pubitemid 37517412)
20. The epidemiology of the dementias: an update. Qiu C, De Ronchi D, Fratiglioni L, Curr Opin Psychiatry 2007 20 4 380 385 10.1097/YCO. 0b013e32816ebc7b 17551353 (Pubitemid 46889665)
21. The Mini-Mental State Examination in general medical practice: clinical utility and acceptance. Tangalos EG, Smith GE, Ivnik RJ, Petersen RC, Kokmen E, Kurland LT, Offord KP, Parisi JE, Mayo Clin Proc 1996 71 9 829 837 10.4065/71.9.829 8790257
22. Changes in alcohol consumption during a ten-year follow-up among Finnish men aged 55-74 years. Kivela SL, Nissinen A, Ketola A, Punsar S, Puska P, Karvonen M, Funct Neurol 1988 3 2 167 178 3402816
23. Associations between use of benzodiazepines or related drugs and health, physical abilities and cognitive function: a non-randomised clinical study in the elderly. Puustinen J, Nurminen J, Kukola M, Vahlberg T, Laine K, Kivela SL, Drugs Aging 2007 24 12 1045 1059 10.2165/00002512-200724120-00007 18020536 (Pubitemid 350145412)
24. Psychotropic drug use and cognitive decline among older men and women. Dealberto MJ, McAvay GJ, Seeman T, Berkman L, Int J Geriatr Psychiatry 1997 12 5 567 574 10.1002/(SICI)1099-1166(199705)12:5<567::AID-GPS552>3.0.CO;2-V 9193967 (Pubitemid 27239061)
25. Benzodiazepines may have protective effects against Alzheimer disease. Fastbom J, Forsell Y, Winblad B, Alzheimer Dis Assoc Disord 1998 12 1 14 17 10.1097/00002093-199803000-00002 9539405 (Pubitemid 29108157)
26. The acute effects of amisulpride (50 mg and 200 mg) and haloperidol (2 mg) on cognitive function in healthy elderly volunteers. Legangneux E, McEwen J, Wesnes KA, Bergougnan L, Miget N, Canal M, L'Heritier C, Pinquier JL, Rosenzweig P, J Psychopharmacol 2000 14 2 164 171 10.1177/026988110001400206 10890311 (Pubitemid 30389490)
27. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers. Allain H, Tessier C, Bentue-Ferrer D, Tarral A, Le Breton S, Gandon M, Bouhours P, Psychopharmacology (Berl) 2003 165 4 419 429 (Pubitemid 36223084)
28. Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. Todorova A, Vonderheid-Guth B, Dimpfel W, J Clin Pharmacol 2001 41 6 636 644 10.1177/00912700122010528 11402632 (Pubitemid 32493358)
29. Age and sex as factors modifying the function of the blood-cerebrospinal fluid barrier. Pakulski C, Drobnik L, Millo B, Med Sci Monit 2000 6 2 314 318 11208329 (Pubitemid 30313168)
30. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I, J Neurol Neurosurg Psychiatry 2003 74 1 70 76 10.1136/jnnp.74.1.70 12486269 (Pubitemid 36069039)